Devices & Diagnostics

Caputron Medical’s mindGear device gets FDA approval for drug-free depression and anxiety treatment

Treatment for depression, anxiety and insomnia doesn't necessarily need to be provided with the help of pharmaceuticals. Caputron is demonstrating that with its mindGear device.

Caputron Medical has announced the FDA approval of its mindGear headset, a device designed to treat depression, insomnia and anxiety without the use of drugs.

The device, which uses neuromodulation, has undergone therapy optimization and clinical testing at world leading medical centers, including Harvard Medical School, over the past 5 years serves as a solution for those who have not experienced relief after pharmaceutical treatment.

Jennifer Higgins, Vice President for U.S. Sales said in a statement: “mindGear represents a major advance in the wearable tech and digital health space. Portable, personal, and customizable, mindGear is both a consumer and medical neuromodulation device.”

The prescribed device is battery powered and connects to the head through hydroPod electrodes. The therapy is described as painless and sessions last approximately 30 minutes. It is available at mindGear.CaputronMedical.com

Caputron CEO Robin Azzam said in a company statement: “Neuromodulation, also called electroceuticals, is the fastest growing area in the treatment of neurological and psychiatric disorders. mindGear further establishes Caputron Medical as a leader in the personalized therapy space with a hand-held and personalized device.”

 Photo: Screenshot via Caputron

Shares0
Shares0